{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:03:52Z","timestamp":1791007432471,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1067\/mhj.2002.126115","type":"journal-article","created":{"date-parts":[[2003,1,9]],"date-time":"2003-01-09T09:50:03Z","timestamp":1042105803000},"page":"470-477","source":"Crossref","is-referenced-by-count":111,"title":["Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study"],"prefix":"10.1067","volume":"144","author":[{"given":"Marc","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Th\u00e9roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Borzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Senatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Lis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Bigonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2002.126115_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination anti-thrombotic therapy in unstable rest angina and non-q wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126115_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","author":"Fragmin during Instability in Coronary Artery Disease (FRISC) study group","year":"1996","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.126115_bib3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126115_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126115_bib5","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.100.15.1602","article-title":"Enoxaparin for unstable angina\/non-Q-wave myocardial infarction: meta-analysis of TIMI 11B and ESSENCE","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126115_bib6","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","author":"The PRISM Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126115_bib7","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","author":"The PRISM-PLUS Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126115_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","author":"The PURSUIT Trial Investigators","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126115_bib9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1067\/mhj.2000.106915","article-title":"Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy","volume":"139","author":"Cohen","year":"2000","journal-title":"Am Heart J"},{"key":"10.1067\/mhj.2002.126115_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1067\/mhj.2002.126115_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0167-5273(99)00171-0","article-title":"Combination therapy with tirofiban and enoxaparin in acute coronary syndromes","volume":"71","author":"Cohen","year":"1999","journal-title":"Int J Cardiol"},{"key":"10.1067\/mhj.2002.126115_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/0003-4819-115-4-256","article-title":"Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI), Phase II Trial","volume":"115","author":"Bovill","year":"1991","journal-title":"Ann Int Med"},{"key":"10.1067\/mhj.2002.126115_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI109661","article-title":"Effect of heparin and heparin fractions on platelet aggregation","volume":"65","author":"Salzman","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1067\/mhj.2002.126115_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.97.3.251","article-title":"Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with a low-molecular-weight heparin and with a direct thrombin inhibitor","volume":"97","author":"Xiao","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126115_bib15","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126115_bib16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","article-title":"Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban","volume":"354","author":"Heeschen","year":"1999","journal-title":"Lancet"},{"key":"10.1067\/mhj.2002.126115_bib17","article-title":"The INTERACT Trial","author":"Goodman","year":"2002"},{"key":"10.1067\/mhj.2002.126115_bib18","first-page":"365A","article-title":"The use of enoxaparin and IIb\/IIIa antagonists in acute coronary syndromes, including PCI: the NICE 3 study [abstract]","volume":"37","author":"Ferguson","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.126115_bib19","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularization: the GUSTO IV-ACS randomised trial","volume":"357","author":"The GUSTO IV-ACS Investigators","year":"2001","journal-title":"Lancet"},{"issue":"2 Suppl","key":"10.1067\/mhj.2002.126115_bib20","first-page":"II-591","article-title":"The promise of LMW heparin and platelet glycoprotein IIb\/IIIa inhibition\u2014results from PARAGON B [abstract]","volume":"102","author":"Mukherjee","year":"2000","journal-title":"Circulation"},{"issue":"2 Suppl","key":"10.1067\/mhj.2002.126115_bib21","first-page":"II-377","article-title":"Is low molecular weight heparin in combination with platelet IIb\/IIIa inhibitors safe and effective? [abstract]","volume":"102","author":"Kovar","year":"2000","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302001114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302001114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T13:58:32Z","timestamp":1554818312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870302001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0002870302001114"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2002.126115","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}